Medication adherence in schizophrenia: factors influencing adherence and consequences of nonadherence, a systematic literature review
TLDR
Improving adherence in schizophrenia may have a considerable positive impact on patients and society by focusing on the identified multitude of factors driving nonadherence, including lack of insight, medication beliefs and substance abuse.Abstract:
Background:Nonadherence to medication is a recognized problem and may be the most challenging aspect of treatment.Methods:We performed a systematic review of factors that influence adherence and the consequences of nonadherence to the patient, healthcare system and society, in patients with schizophrenia. Particular attention was given to the effect of nonadherence on hospitalization rates, as a key driver of increased costs of care. A qualitative systematic literature review was conducted using a broad search strategy using disease and adherence terms. Due to the large number of abstracts identified, article selection was based on studies with larger sample sizes published after 2001. Thirty-seven full papers were included: 15 studies on drivers and 22 on consequences, of which 12 assessed the link between nonadherence and hospitalization.Results:Key drivers of nonadherence included lack of insight, medication beliefs and substance abuse. Key consequences of nonadherence included greater risk of relapse,...read more
Citations
More filters
Journal ArticleDOI
Psychotropic medication non-adherence and its associated factors among patients with major psychiatric disorders: a systematic review and meta-analysis
Agumasie Semahegn,Agumasie Semahegn,Kwasi Torpey,Adom Manu,Nega Assefa,Gezahegn Tesfaye,Augustine Ankomah +6 more
TL;DR: Individual patient’s behaviors, lack of social support, clinical or treatment and illness-related, and health system factors influenced psychotropic medication non-adherence, which was influenced by various factors operating at different levels.
Journal ArticleDOI
Efficacy and Safety of Paliperidone Palmitate 3-Month Formulation for Patients with Schizophrenia: A Randomized, Multicenter, Double-Blind, Noninferiority Study
Adam Savitz,Haiyan Xu,Srihari Gopal,Isaac Nuamah,Paulien Ravenstijn,Adam Janik,Alain Schotte,David Hough,W. Wolfgang Fleischhacker +8 more
TL;DR: PP3M was noninferior to PP1M: relapse rates were similar in both groups and increased weight was the most common treatment-emergent adverse event (double-blind phase; 21% each).
Journal ArticleDOI
Clinical and economic impact of non-adherence to antidepressants in major depressive disorder: A systematic review
Siew Ching Ho,Huey Yi Chong,Nathorn Chaiyakunapruk,Balamurugan Tangiisuran,Sabrina Anne Jacob,Sabrina Anne Jacob +5 more
TL;DR: There is a strong association between non-adherence to antidepressants and a worsening of patients' clinical and economic outcomes and cost-effective interventions should be directed to this group of patients to improve medication adherence.
Journal ArticleDOI
Polygenic overlap between schizophrenia risk and antipsychotic response: a genomic medicine approach.
Douglas M. Ruderfer,Alexander W. Charney,Ben Readhead,Brian A. Kidd,Anna K. Kähler,Paul J. Kenny,Michael J. Keiser,Jennifer L. Moran,Christina M. Hultman,Stuart A. Scott,Patrick F. Sullivan,Shaun Purcell,Joel T. Dudley,Pamela Sklar +13 more
TL;DR: The results support genetic overlap between schizophrenia pathogenesis and antipsychotic mechanism of action and provide evidence of a role for rare functional variants in antipsychotics treatment response, pointing to a subset of patients where their genetic information could inform treatment.
Journal ArticleDOI
Does relapse contribute to treatment resistance? Antipsychotic response in first- vs. second-episode schizophrenia.
Hiroyoshi Takeuchi,Hiroyoshi Takeuchi,Cynthia Siu,Gary Remington,Gagan Fervaha,Gagan Fervaha,Robert B. Zipursky,Robert B. Zipursky,George Foussias,Ofer Agid,Ofer Agid +10 more
TL;DR: It is suggested that antipsychotic treatment response is reduced or delayed in the face of relapse following effective treatment of the first episode of schizophrenia.
References
More filters
Journal ArticleDOI
Factors associated with adherence to treatment with olanzapine and other atypical antipsychotic medications in patients with schizophrenia.
TL;DR: Significant improvement in positive symptoms, regardless of treatment, followed by significant improvement in hostility and depressive symptoms, may best predict treatment adherence.
Journal ArticleDOI
Denial and acceptance coping styles and medication adherence in schizophrenia.
TL;DR: It was found that denial coping was inversely related to medication adherence, and targeting denial coping strategies in treatment may help foster more optimal strategies for managing schizophrenia.
Journal Article
Partial compliance with antipsychotics increases mental health hospitalizations in schizophrenic patients: analysis of a national managed care database.
Chris M. Kozma,Peter J. Weiden +1 more
TL;DR: Small decreases in compliance with antipsychotics are associated with increased hospitalization risk among patients with schizophrenia in a managed care population.
Journal ArticleDOI
Switching antipsychotics in inpatient schizophrenia care: Predictors and outcomes
TL;DR: Remaining on FGAs or switching to SGAs in schizophrenia care depends strongly on institutional practices in addition to the previous disease course and health care utilization.
Journal Article
Nonadherence to antipsychotic treatment in patients with schizophrenic disorders.
Jaromír Švestka,István Bitter +1 more
TL;DR: There are several factors that cause treatment nonadherence in schizophrenia: causes derived from the schizophrenic disorder itself, patient characteristics, causes associated associated with the health-care system, and the antipsychotic treatment itself.
Related Papers (5)
The expert consensus guideline series: adherence problems in patients with serious and persistent mental illness.
Alan S. Bellack,Charles L. Bowden,Christopher R. Bowie,Matthew J. Byerly,William T. Carpenter,Laurel A. Copeland,Albana M Dassori,John M. Davis,Colin A. Depp,Esperanza Diaz,Lisa B. Dixon,John P. Docherty,Eric B. Elbogen,S. Nasser Ghaemi,Paul E. Keck,Samuel J. Keith,Martijn J. Kikkert,John Lauriello,Barry D. Lebotz,Stephen R. Marder,Joseph P. McEvoy,David J. Miklowitz,Alexander L. Miller,Paul A. Nakonezny,Henry A. Nasrallah,Michael W. Otto,Roy H. Perlis,Delbert G. Robinson,Gary S. Sachs,Martha Sajatovic,Nina R. Schooler,S. Charles Schulz,Jan Scoff,Jair C. Soares,Stephen M. Strakowski,Holly A. Swartz,Marcia Valenstein,Dawn I. Velligan,Peter J. Weiden,Emily M. Woltmann,John E. Zeber +40 more